510(k) K140455

CAPTIA MEASLES IGM by Trinity Biotech USA — Product Code PCL

K140455 is an FDA 510(k) premarket notification submitted by Trinity Biotech USA for the device "CAPTIA MEASLES IGM". The FDA issued a decision of Substantially Equivalent on May 22, 2014. The device falls under product code PCL (Enzyme Linked Immunoabsorbent Assay, Rubeola Igm), a Class I device regulated under 21 CFR 866.3520. Trinity Biotech USA has 10 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
May 22, 2014
Date Received
Feb 24, 2014
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Rubeola Igm
Device Class
Class I
Regulation Number
866.3520
Review Panel
MI
Submission Type
510(k) Exempt

The qualitative detection of measles specific IgM antibodies in serum or plasma.

Need the full FDA record for Trinity Biotech USA? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K140455. Report a data issue: hello@regdatalab.com.